China Pharma Holdings
CPHI
9 hedge funds and large institutions have $210K invested in China Pharma Holdings in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 9 → 9 (0)
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
42% less capital invested
Capital invested by funds: $362K → $210K (-$152K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.75K |
| 2 |
BWL
Bogart Wealth LLC
Mclean,
Virginia
|
+$270 |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$270 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$24K |
| 2 |
Renaissance Technologies
New York
|
-$19.8K |
| 3 |
Bank of New York Mellon
New York
|
-$4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.83K |
| 5 |
VF
Virtu Financial
New York
|
-$135 |
CPHI Hedge Fund Activity: Q2 2018 in Review
9 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q2 2018, worth a combined $210K — down 42% from $362K a quarter earlier.
Fund positioning in CPHI was balanced in Q2 2018: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 4 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $1.75K. The largest seller was Citadel Advisors, cutting an estimated $24K.
- 9 institutional investors held China Pharma Holdings (CPHI) as of Q2 2018, unchanged from Q1 2018.
- Funds reported $210K of China Pharma Holdings stock for Q2 2018, down 42% quarter-over-quarter.
- 1 fund opened new China Pharma Holdings positions in Q2 2018 and 1 closed out, a net change of 0 holders.
- The largest China Pharma Holdings buyer in Q2 2018 was Susquehanna International Group, an estimated $1.75K added.
- The largest China Pharma Holdings seller in Q2 2018 was Citadel Advisors, an estimated $24K sold.
Based on aggregated 13F filings for Q2 2018.